Gendron R L, Good W V, Adams L C, Paradis H
Department of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology and Oncology, The Children's Hospital Research Foundation, Cincinnati, Ohio 45229, USA.
Invest Ophthalmol Vis Sci. 2001 Nov;42(12):3000-7.
Retinal neovascularization occurring as a complication of diabetes mellitus can cause vision loss and blindness. The identification and study of novel genes involved in retinal angiogenesis may define new targets to suppress retinal neovascularization in diabetes and other ocular diseases. A novel acetyltransferase subunit, tubedown-1 (tbdn-1), has been isolated, the expression of which is regulated during blood vessel development. Tbdn-1 is not detected in most adult vascular beds but persists at high levels in the adult ocular vasculature. The purpose of this study was to gain insight into the possible role of tbdn-1 in retinal blood vessels by characterizing its expression patterns in adult homeostasis and in retinal neovascularization associated with diabetes.
Western blot analysis and immunohistochemistry were performed to study the expression patterns of tbdn-1 during adult homeostasis in normal human retinas, in a model of choroid-retina endothelial capillary outgrowth in vitro, and in retinas showing neovascularization in patients with proliferative diabetic retinopathy (PDR).
In adults during homeostasis, tbdn-1 was expressed highly in normal endothelium of retinal and limbic blood vessels. Tbdn-1 was also expressed in RF/6A, a rhesus macaque choroid-retina-derived endothelial cell line. In an in vitro model system using the RF/6A cell line, tbdn-1 expression was downregulated during the outgrowth of these cells into capillary-like structures on a reconstituted basement membrane matrix. Similar to this in vitro model, tbdn-1 expression is specifically suppressed in the endothelial cells of blood vessels and capillary fronds in vivo in both the neural retinal tissue and in preretinal membranes in eyes of patients with PDR.
High levels of expression of tbdn-1 are associated with ocular endothelial homeostasis in adults. Conversely, low levels of tbdn-1 expression are associated with endothelial capillary outgrowth in vitro and retinal neovascularization in vivo. Because the tbdn-1 acetyltransferase subunit is a member of a family of regulatory enzymes that are known to control a range of processes, including cell growth and differentiation, through posttranslational modification, the current results support a hypothesis that tbdn-1 may be involved in maintaining homeostasis and preventing retinal neovascularization.
糖尿病并发症引起的视网膜新生血管可导致视力丧失和失明。鉴定和研究参与视网膜血管生成的新基因可能会确定抑制糖尿病及其他眼部疾病中视网膜新生血管的新靶点。一种新的乙酰转移酶亚基,即tube down-1(tbdn-1)已被分离出来,其表达在血管发育过程中受到调控。在大多数成体血管床中未检测到Tbdn-1,但在成体眼部血管系统中持续高水平表达。本研究的目的是通过表征其在成体稳态以及与糖尿病相关的视网膜新生血管中的表达模式,深入了解tbdn-1在视网膜血管中的可能作用。
采用蛋白质免疫印迹分析和免疫组织化学方法,研究tbdn-1在正常成人视网膜的成体稳态、体外脉络膜-视网膜内皮细胞毛细血管生长模型以及增殖性糖尿病视网膜病变(PDR)患者出现新生血管的视网膜中的表达模式。
在成体稳态期间,tbdn-1在视网膜和边缘血管的正常内皮细胞中高表达。Tbdn-1也在RF/6A(一种恒河猴脉络膜-视网膜来源的内皮细胞系)中表达。在使用RF/6A细胞系的体外模型系统中,当这些细胞在重组基底膜基质上生长成毛细血管样结构时,tbdn-1表达下调。与该体外模型相似,在PDR患者眼睛的神经视网膜组织和视网膜前膜中的血管和毛细血管襻的内皮细胞中,tbdn-1表达在体内被特异性抑制。
tbdn-1的高水平表达与成人眼部内皮稳态相关。相反,tbdn-1的低水平表达与体外内皮细胞毛细血管生长和体内视网膜新生血管相关。由于tbdn-1乙酰转移酶亚基是已知通过翻译后修饰控制一系列过程(包括细胞生长和分化)的调节酶家族的成员,目前的结果支持tbdn-1可能参与维持稳态和预防视网膜新生血管的假说。